PLSCR1 Regulates the Physiology of Fibroblast-Like Synoviocytes via Modulating the STAT1 Signaling Pathway

Tianhua Chen1, Jiaojiao Wang2

  • 1Department of Pain Management, The Sixth Hospital of Wuhan, Affiliated Hospital of Jianghan University, Wuhan, China.

PubMed
Abstract

Insights

Phospholipid scramblase 1 (PLSCR1) is elevated in rheumatoid arthritis (RA) patients. It drives inflammation and joint damage by affecting fibroblast-like synoviocyte (FLS) proliferation and apoptosis via the STAT1 pathway, suggesting PLSCR1 as a therapeutic target.

Area of Science:

  • Immunology
  • Molecular Biology
  • Rheumatology

Background:

  • Rheumatoid arthritis (RA) involves chronic synovial inflammation and joint destruction.
  • Understanding RA pathogenesis is key to developing new therapies.
  • Phospholipid scramblase 1 (PLSCR1) is linked to autoimmune diseases, but its role in RA is unknown.

Purpose of the Study:

  • To investigate the role and mechanism of PLSCR1 in rheumatoid arthritis.
  • To determine if PLSCR1 is a potential therapeutic target for RA.

Main Methods:

  • Quantified PLSCR1 serum expression in RA patients versus healthy controls using RT-qPCR.
  • Assessed PLSCR1 function in human fibroblast-like synoviocytes (HFLSs) via siRNA knockdown.
  • Measured HFLS proliferation, apoptosis, and cytokine release (TNF-α, IL-1β, IL-6); explored PLSCR1-STAT1 interaction.

Main Results:

  • PLSCR1 serum levels were significantly higher in RA patients.
  • PLSCR1 knockdown in HFLSs reduced proliferation, increased apoptosis, and lowered inflammatory cytokine levels.
  • PLSCR1 knockdown also decreased STAT1 expression; STAT1 activation reversed these effects.

Conclusions:

  • PLSCR1 is upregulated in RA and influences FLS proliferation, apoptosis, and inflammation through the STAT1 pathway.
  • PLSCR1 represents a potential molecular target for rheumatoid arthritis treatment.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.9K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
9.8K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.5K
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
3.2K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
17.2K
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
15.9K